Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
Profitability Metrics
Gross Margin
20.36%
Operating Margin
17.71%
Net Margin
0.75%
Efficiency Metrics
Revenue per Expense Ratio
1.20
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
36.20%
Income Tax Rate
-8,788,263,900.0%
EPS
0.0295000000
Balance Sheet Analysis
Current Ratio
0.63
Cash Ratio
0.03
Working Capital
$-618.84M
Debt to Equity
1.70
Debt to Assets
46.54%
Equity Ratio
27.43%
Cash Flow Analysis
Operating Cash Flow Ratio
23.28%
Free Cash Flow Ratio
-14.76%
CapEx to Revenue
38.03%
Dividends Paid
$336.89M
Stock Buybacks
$2.43M
Total Shareholder Returns
$339.32M
Cash Position Change
-24.75%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Detailed Growth Metrics
Core Performance
Revenue
4.00%
Net Income
109.98%
EPS
109.83%
Operating Income
11.12%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
19.42%
Operating Cash Flow
5.63%
Free Cash Flow
16.50%
Balance Sheet Health
Assets
4.28%
Debt
13.55%
Book Value per Share
-4.47%
Inventory
1.03%
Shareholder Returns
Dividends per Share
-10.86%
Shares Outstanding
1.61%
Long Term Trends
3Y Revenue/Share
26.32%
5Y Revenue/Share
16.70%
3Y Dividend/Share
-0.82%
5Y Dividend/Share
36.48%